Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what assessment he has made of the effectiveness of drugs available on the NHS for the treatment of people diagnosed with (a) MS and (b) Alzheimer's disease.

The National Institute for Health and Care Excellence (NICE) is the independent body which makes decisions on the clinical and cost effectiveness of drugs based on a thorough assessment of the best available evidence. National Health Service commissioners are required to fund drugs and treatments recommended by NICE technology appraisals.

NICE has recommended a number of drugs as treatment options for multiple sclerosis and Alzheimer's disease and further information is available at:

www.nice.org.uk/guidance/conditions-and-diseases/neurological-conditions